This October, Cytokines 2026 brings one of the most consequential figures in cancer immunotherapy to Glasgow. Dr. Carl June, the Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania, will serve as a keynote speaker at the annual meeting of The Cytokine Society — held 18-21 October at the Scottish Event Campus (SEC) in Glasgow, UK.
Dr. June’s landmark research on chimeric antigen receptor (CAR) T cell therapy transformed the treatment of hematologic malignancies. His work contributed directly to the first FDA-approved CAR-T cell therapies for leukemia and lymphoma, and his ongoing research continues to push the boundaries of cellular immunotherapy for cancer and chronic infectious disease. His keynote address promises to be a defining highlight of this year’s program, built around the theme ‘Translating Cytokines.’
A Program Built on Translation
The Cytokines 2026 scientific program features three dynamic plenary sessions that reflect the breadth of the field — from fundamental biology to targeted therapeutic intervention:
Immunometabolism in Health and Disease
Luke O’Neill (Trinity College Dublin), Claudia Mauri (University College London), Tony Tiguim (Monash University), and Miguel Soares (Gulbenkian Institute) explore the intersection of cytokine signaling and metabolic regulation, and its implications for health and disease.
Tackling the Complexities of Immune-Mediated Inflammatory Disease
Iain McInnes (University of Glasgow), Jonathan Cavanagh (University of Glasgow), and Clare Lloyd (Imperial College London) address the clinical and scientific challenges of translating cytokine discoveries into treatments for complex inflammatory conditions.
Next Steps in Cytokine Targeted Interventions
Christopher Hunter (University of Pennsylvania), Doreen Cantrell (University of Dundee), John O’Shea (NIH/NIAMS), and Gerhard Kronke (German Rheumatology Research Center) discuss the evolving landscape of cytokine-targeted therapies and the next generation of clinical applications.
Supporting the Next Generation of Researchers
Cytokines 2026 will also feature a series of career development sessions dedicated to early-career researchers. Supported by the Royal Society and the Learned Society of Wales, these lunchtime sessions will cover academic-industry partnerships and career paths beyond the traditional academic track — including scientific journalism, patent law, industry roles, grant administration, and venture capital. Details will be announced shortly; register your interest when you sign up.
Join Us in Glasgow
Registration is now open. The abstract submission deadline has been extended to 31 May 2026, and early bird registration pricing is available through 26 June 2026. Student and postdoctoral members may apply for travel awards at the time of abstract submission.